Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Point and Frameshift Mutations

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Nonsense-mediated mRNA Decay

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

SMPD4 deficiency disrupts indirect neurogenesis and neuronal migration in gyrencephalic cortex.

Brain : a journal of neurology·2026

Same author

Biomimetic Ion Channel Design for Simultaneous Lithium-Ion Flux Regulation and Interfacial Stabilization in Lithium Metal Batteries.

Small (Weinheim an der Bergstrasse, Germany)·2026

Same author

Multiomic characterization of response and resistance to neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma.

Translational cancer research·2026

Same author

Unraveling the molecular mechanisms of triphenyl phosphate-induced hepatotoxicity: Integrated insights from network toxicology, molecular docking, and transcriptomic evidence.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2026

Same author

Association Between Organophosphate Flame Retardant Exposure and Trouble Sleeping: Integrating Epidemiological Evidence with Mechanistic Insights.

International journal of molecular sciences·2026

Same author

Dynamic Roles of Oxygen Vacancies for Surface Hydroxylation in Enhanced Alkaline Hydrogen Evolution.

Journal of the American Chemical Society·2026

Search research articles

Related Experiment Video

Updated: Sep 2, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

mvPPT: A Highly Efficient and Sensitive Pathogenicity Prediction Tool for Missense Variants.

Shi-Yuan Tong¹, Ke Fan¹, Zai-Wei Zhou²

¹Jing'an District Central Hospital of Shanghai, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai 200032, China.

Genomics, Proteomics & Bioinformatics

|August 8, 2022

Summary

We developed a new tool, missense variant Pathogenicity Prediction Tool (mvPPT), to accurately identify disease-causing genetic variants. This gradient boosting classifier outperforms existing methods, aiding in human genome variant analysis.

Keywords:

Computational biology Genomics Machine learning Missense variant Pathogenicity prediction

More Related Videos

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Identification and Classification of Position-specific GABA_A Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Related Experiment Videos

Last Updated: Sep 2, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Identification and Classification of Position-specific GABA_A Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Area of Science:

Genomics
Bioinformatics
Computational Biology

Background:

Next-generation sequencing (NGS) accelerates human genome variant discovery but complicates pathogenic variant identification.
Accurate classification of missense variants is crucial for understanding genetic disease.

Purpose of the Study:

To develop and validate a highly sensitive and accurate classifier for missense variant pathogenicity.
To provide insights into feature selection and training strategies for variant prediction models.

Main Methods:

Developed the missense variant Pathogenicity Prediction Tool (mvPPT) using a gradient boosting approach.
Utilized high-confidence training sets with diverse variant profiles.
Integrated features including existing predictor scores, allele/amino acid/genotype frequencies, and genomic context.

Main Results:

mvPPT demonstrated superior performance compared to established predictors across various test datasets.
The study identified key features and provided guidance for optimizing training set and feature selection.

Conclusions:

mvPPT offers a robust and accurate solution for missense variant pathogenicity prediction.
The findings contribute to improved variant interpretation and biological understanding of pathogenicity.